CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 57 enrolled
Drug / intervention
nicotine +1 moredrug
Likely dose
nicotine 25 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02102100
NCT02102100N/ACompleted

Menthol's Effects on Nicotine Reinforcement in Smokers

Yale University·interventional·Posted Apr 2, 2014·Updated Mar 19, 2020

In Brief

A clinical study evaluating nicotine and menthol for Nicotine Dependence. Completed, enrolled 57 participants across 2 sites.

Detailed Summary

This study will help determine if menthol administered by inhalation via electronic cigarettes (e-cigarette) changes the reinforcing effects of pure nicotine administered intravenously in cigarette smokers who smoke mentholated or non-mentholated cigarettes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 2, 2014
Enrollment StartMar 26, 2014
Primary CompletionJul 11, 2016
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 12.3 years ago

Interventions

nicotinedrug

In each of 3 test sessions, subjects in each arm will receive a randomized sequence of three intravenous infusions (30 sec each), one hour apart. The infusions will consist of saline, nicotine (.25 mg / 70kg) and nicotine (0.5 mg / 70 kg). The randomized sequence will remain the same between test sessions for a given subject.

mentholdrug

In each of 3 test sessions, subjects will take 6 inhalations from the study e-cigarette, one inhalation every 15 seconds, of the randomized menthol condition for that test session ust prior to each intravenous infusion. The menthol conditions are: 3.2% menthol, 0.5% menthol and tobacco-flavor only (0.0% menthol)